Lyell re­ports pa­tient death, ear­ly re­spons­es in sol­id tu­mor CAR-T tri­al

In an ear­ly-stage clin­i­cal tri­al with a hand­ful of pa­tients, Lyell Im­munophar­ma’s ex­per­i­men­tal CAR-T ther­a­py for sol­id tu­mor can­cers showed hints of ef­fi­ca­cy but al­so …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.